Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;17(5):e2293.
doi: 10.1002/rcs.2293. Epub 2021 Jun 15.

Robot-assisted kidney transplantation is a safe alternative approach for morbidly obese patients with end-stage renal disease

Affiliations

Robot-assisted kidney transplantation is a safe alternative approach for morbidly obese patients with end-stage renal disease

Seung Duk Lee et al. Int J Med Robot. 2021 Oct.

Abstract

Background: Many centres deny obese patients with a body mass index (BMI) >35 access to kidney transplantation due to increased intraoperative and postoperative complications.

Methods: From August 2017 to December 2019, 73 consecutive cases of kidney transplantation in morbidly obese patients were enrolled at a single university at the initiation of a robotic transplant surgery program. Outcomes of patients who underwent robotic assisted kidney transplant (RAKT) were compared to frequency-matched patients undergoing open kidney transplant (OKT).

Results: A total of 24 morbidly obese patients successfully underwent RAKT, and 49 obese patients received an OKT. The RAKT group developed fewer surgical site infections (SSI) than the OKT group. Graft function, creatinine, and glomerular filtration rate (GFR) were similar between groups 1 year after surgery. Graft and patient survival were 100% for both groups.

Conclusions: RAKT offers a safe alternative for morbidly obese patients, who may otherwise be denied access to OKT.

Keywords: kidney; kidney transplant; morbid obesity; robotic surgery; surgical-site infection.

PubMed Disclaimer

References

REFERENCES

    1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284-2291. https://doi.org/10.1001/jama.2016.6458
    1. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17(5):1453-1459. https://doi.org/10.1681/ASN.2005111241
    1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-2047. https://jamanetwork.com/
    1. Friedman AN, Miskulin DC, Rosenberg IH, Levey AS. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis. 2003;41(2):480-487. https://doi.org/10.1053/ajkd.2003.50059
    1. McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrol. 2019;30(1):127-135. https://doi.org/10.1681/ASN.2018050531

LinkOut - more resources